We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 39,392

The Medicaid Fraud Control Units: Fiscal Year 2014 Report
  • Foley & Lardner LLP
  • USA
  • May 27 2015

The Department of Health and Human Services (HHS) Office of Inspector General (HHS-OIG) has released its Fiscal Year (FY) 2014 Annual Report (Report


Health care update - May 26, 2015
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • May 26 2015

Despite a delay in the markup of the 21st Century Cures Act (H.R. 6) caused by ongoing negotiations over offsets and


EEOC issues proposed rule with respect to wellness programs
  • Weil Gotshal & Manges LLP
  • USA
  • May 26 2015

On April 16, 2015, the Equal Employment Opportunity Commission (the EEOC) released its proposed rule (the Proposed Rule) that would amend the


HHS revises, delays Medicare enrollment requirements for Part D prescriptions
  • Benesch Friedlander Coplan & Aronoff LLP
  • USA
  • May 26 2015

The Affordable Care Act authorized the Department of Health and Human Services (HHS) to require a physician, dentist or other healthcare provider to


NJ court affirms role of learned intermediary doctrine
  • Shook Hardy & Bacon LLP
  • USA
  • May 26 2015

A New Jersey court overseeing the centralized litigation regarding the human tissue product AlloDerm has issued a noteworthy ruling in a bellwether


A funny thing happened on the way to the pharmacists meeting
  • Arnall Golden Gregory LLP
  • USA
  • May 26 2015

The Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) issued recently a Notice of Violation to a generic drug company


Pharmaceutical marketing and unfair-trade-practices claims
  • Ellis & Winters
  • USA
  • May 26 2015

Lawsuits against pharmaceutical companies generally center on product-liability claims. A new trend in pharma cases, however, is to include a


Much Ado about nothing: recent activity in Florida’s medical marijuana landscape
  • Berger Singerman LLP
  • USA
  • May 26 2015

Despite a recent flurry of activity among lawmakers, lobbyists, as well as would-be medical marijuana growers and business operators, the failure of


California Medicare appeal applies strict standing rules
  • Duane Morris LLP
  • USA
  • May 26 2015

The Medicare Part B appeal process is lengthy and cumbersome, typically requiring full exhaustion of administrative remedies, including an


Cybercrime on the rise: targeting banking institutions and insurance companies
  • Wilson Elser
  • USA
  • May 26 2015

Security experts are warning that 2015 is the "Year of the Healthcare Hack" as media outlets continue to report on a number of high-profile companies